EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank21
3Y CAGR-37.2%
5Y CAGR-18.7%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-37.2%/yr
vs -18.1%/yr prior
5Y CAGR
-18.7%/yr
Recent deceleration
Acceleration
-19.1pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.07M | -44.3% |
| 2024 | $3.71M | -19.9% |
| 2023 | $4.63M | -44.4% |
| 2022 | $8.33M | +1.8% |
| 2021 | $8.18M | +40.4% |
| 2020 | $5.82M | +116.7% |
| 2019 | $2.69M | -85.5% |
| 2018 | $18.50M | - |
| 2017 | $0.00 | -100.0% |
| 2016 | $815000.00 | - |